DMRADamora Therapeutics, Inc.
What is the market doing?
No clear lean: insiders net buying, but in a downtrend (−17% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −17% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 22, 2026.
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Level with the previous count, up from 5.8% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DMRA is trading
Damora Therapeutics, Inc. is +92% over the past year while the S&P 500 is +16%: 76 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −17%
vs 200-day average · a clear downtrend
- RSI (14)
- 55
RSI (14) · neutral
- Below its 52-week high
- 38%
Below its 52-week high
Details›
- Last close2026-10-23
- $21.12
- 1 monthS&P 500 −0.94%
- +4.3%
- 1 yearS&P 500 +16%
- +92%
- 5 yearsS&P 500 +86%
- −75%
- vs 50-day average$24.51
- −14%
- 52-week high
- $34.14
- 52-week low
- $4.95
- Annualised volatility
- 342%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $246K
| Year | Return |
|---|---|
| 2026 (year to date) | −8.2% |
| 2025 | +395% |
| 2024 | −74% |
| 2023 | −37% |
| 2022 | −62% |
| 2021 | −76% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +14% |
| Feb | 6 | 2 of 6 | −4.2% |
| Mar | 6 | 2 of 6 | −11% |
| Apr | 6 | 0 of 6 | −11% |
| May | 6 | 2 of 6 | −1.5% |
| Jun | 6 | 4 of 6 | +6.1% |
| Jul | 6 | 3 of 6 | +4.8% |
| Aug | 6 | 2 of 6 | −11% |
| Sep | 6 | 3 of 6 | −3.1% |
| Oct | 6 | 2 of 6 | +4.0% |
| Nov | 6 | 3 of 6 | +17% |
| Dec | 6 | 3 of 6 | −1.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.